<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[amylin Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/amylin.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to amylin]]></description>
	<s:counts start="0" returned="11" found="11" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Amylin's Eastham Says Eastbourne's Behrens Is Not Telling the Truth About $20 Share Bid]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002151/amylins-eastham-says-eastbournes-behrens-is-not-telling-the-truth-about-20-share-bid/]]></link>
		<description><![CDATA[Amylin director Karin Eastham has, in essence, called Eastbourne Capital board candidate M. Kathleen Behrens a liar or at least an amnesiac. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 14 May 2009 13:20:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[Board]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin v. Eastbourne Slideshow Battle; It's All About the Stock Price]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001980/amylin-v-eastbourne-slideshow-battle-what-will-that-byetta-factory-cost/]]></link>
		<description><![CDATA[Amylin and Eastbourne Capital, locked in a fight for control of Amylin's board of directors, have escalated their war in the only way that beancounters know how: duelling presentations.    You can see Amylin's here and a summary of Eastbourne's here.    Eastbourne has kept it...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 06 May 2009 08:30:01 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/stock+price.html"><![CDATA[Stock Price]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[Board]]></category>
		<category domain="http://resources.bnet.com/topic/eastbourne+capital.html"><![CDATA[Eastbourne Capital]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[In U-Turn, Amylin Lays Off 200; Move Validates Icahn's Arguments]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001959/in-u-turn-amylin-lays-off-200-move-validates-icahns-arguments/]]></link>
		<description><![CDATA[Amylin says it will lay off 200 drug sales reps, or 35 percent of its force, in order to save $45 billion in costs. The move is an embarrassing U-turn for Amylin, which only days ago was arguing fiercely that after laying off 340 people last November it had cut...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 05 May 2009 10:27:25 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/move.html"><![CDATA[Move]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/recruitment+%2526+selection.html"><![CDATA[Recruitment & Selection]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin Trial Testimony: Debt Not Structured With Interest or Principal Payments in Mind]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001942/amylin-trial-testimony-debt-not-structured-with-interest-or-principal-payments-in-mind/]]></link>
		<description><![CDATA[Amylin's "poison put" debt deals were not structured primarily to protect interest and principal payments but to trigger a sudden bulk repayment, according to Professor Michael Roberts of Harvard Business School. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 05 May 2009 07:50:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[Payment]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[The War for Amylin: Lilly Not Interested; Icahn Calls the Company a "Dictatorship"]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001849/the-war-for-amylin-lilly-not-interested-icahn-calls-the-company-a-dictatorship/]]></link>
		<description><![CDATA[Eli Lilly CEO John Lechleiter complicated the battle for Amylin today by telling Reuters he was not interested in buying the company.    It was widely suspected that investor Carl Icahn, who is in a three-way war for control of Amylin's board of directors, wants to dress up...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 28 Apr 2009 12:23:57 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[Board]]></category>
		<category domain="http://resources.bnet.com/topic/carl+icahn.html"><![CDATA[Carl Icahn]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Arena Lays Off 31% of Its Staff Following Obesity Trial Failure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001832/arena-lays-off-31-of-its-staff-following-obesity-trial-failure/]]></link>
		<description><![CDATA[Arena Pharmaceuticals is to lay off 31 percent, or 130 employees, before June 22, the company told the SEC. Arena staffers -- whose future is dependent on an anti-obesity drug, lorcaserin -- may be forgiven for wondering how it has all gone wrong so quickly.  In February, Arena CEO...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 27 Apr 2009 12:23:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin CEO Got 11% Pay Rise Despite Losses; Company Paid $355K for Lawyer to Move House]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001763/amylin-ceo-got-11-pay-rise-despite-losses-company-paid-355k-for-lawyer-to-move-house/]]></link>
		<description><![CDATA[Combined executive pay at Amylin rose 10.2 percent last year even though the company lost 50 percent more money than it did the year before, according to a filing with the SEC. Amylin has not made a profit in the last five years, despite its revenues going from zero to...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 22 Apr 2009 08:32:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[Compensation]]></category>
		<category domain="http://resources.bnet.com/topic/san+diego.html"><![CDATA[San Diego]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[Director]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/taxes.html"><![CDATA[Taxes]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin Insists Byetta Doesn't Cause Cancer; Wall Street Doesn't Seem So Sure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001760/amylin-insists-byetta-doesnt-cause-cancer-wall-street-doesnt-seem-so-sure/]]></link>
		<description><![CDATA[Amylin CEO Daniel Bradbury may be wishing that Novo Nordisk's failed competitor to its diabetes drug Byetta had actually been approved by the FDA. Had Novo's liraglutide passed muster, no one would have gotten the jitters over whether Byetta gives you cancer or not.    At Amylin's conference...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 21 Apr 2009 13:27:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/byetta.html"><![CDATA[Byetta]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Inside Amylin's Anti-Icahn Suicide Pact]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001549/inside-amylins-anti-icahn-suicide-pact/]]></link>
		<description><![CDATA[Amylin has adopted a financial suicide pact which, in the company's own words, may bankrupt the company if dissident investors Carl Icahn and Eastbourne Capital get a majority of directors elected at the May 27 shareholder meeting.    The pact is described in a lawsuit brought by a...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 01 Apr 2009 08:54:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[Board]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[Director]]></category>
		<category domain="http://resources.bnet.com/topic/carl+icahn.html"><![CDATA[Carl Icahn]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+stock.html"><![CDATA[Amylin Stock]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin Battle Heats Up as Eastbourne Capital Touts Rival Directors' Slate to Icahn's]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000802/battle-for-amylin-heats-up-as-eastbourne-capital-touts-rival-directors-slate-to-icahns/]]></link>
		<description><![CDATA[Eastbourne Capital has proposed a five-member team of its own for Amylin's board. Carl Icahn proposed his own slate last week. Both sets of investors are unhappy with the company that has a joint venture with Eli Lilly on diabetes drug Byetta.    Eastbourne said of its move:...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 02 Feb 2009 15:08:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/slate.html"><![CDATA[SLATE]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[Board]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[Director]]></category>
		<category domain="http://resources.bnet.com/topic/eastbourne+capital.html"><![CDATA[Eastbourne Capital]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="tickers">LLY</category>
	</item>
	<item>
		<title><![CDATA[Directors Roster: a quarterly record of new director appointments]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_go2446/is_3_31/ai_n29348831]]></link>
		<description><![CDATA[THE DIRECTORS & BOARDS Directors Roster--a quarterly record of new director appointments--is compiled from public and private sources by the editorial staff of DIRECTORS & BOARDS and is sponsored by Heidrick & Struggles. Please forward your directors' appointments to kmccarthy@directorsandboards.com.  Submissions of new directors and appointments are welcome from...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acorda+therapeutics+inc..html"><![CDATA[Acorda Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/albemarle+corp..html"><![CDATA[Albemarle Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amylin.html"><![CDATA[Amylin]]></category>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/career.html"><![CDATA[career]]></category>
		<category domain="http://resources.bnet.com/topic/celanese+corp..html"><![CDATA[Celanese Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/chairman.html"><![CDATA[chairman]]></category>
		<category domain="http://resources.bnet.com/topic/clayton+holdings+inc..html"><![CDATA[Clayton Holdings Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/computer+associates+international+inc..html"><![CDATA[Computer Associates International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/deltic+timber+corp..html"><![CDATA[Deltic Timber Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/dentsply+international+inc..html"><![CDATA[DENTSPLY International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[director]]></category>
		<category domain="http://resources.bnet.com/topic/dominion+homes+inc..html"><![CDATA[Dominion Homes Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ducommun+inc..html"><![CDATA[Ducommun Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ecolab+inc..html"><![CDATA[Ecolab Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/factset+research+systems+inc..html"><![CDATA[FactSet Research Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/fpl+group+inc..html"><![CDATA[FPL Group Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gainsco+inc..html"><![CDATA[Gainsco Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/harte-hanks+inc..html"><![CDATA[Harte-Hanks Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/hartford+financial+services+group+inc..html"><![CDATA[Hartford Financial Services Group Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthways+inc..html"><![CDATA[Healthways Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/kinetic+concepts+inc..html"><![CDATA[Kinetic Concepts Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/labranche+%2526+co.+inc..html"><![CDATA[LaBranche & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/m..html"><![CDATA[M.]]></category>
		<category domain="http://resources.bnet.com/topic/mattson+technology+inc..html"><![CDATA[Mattson Technology Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/president.html"><![CDATA[president]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/roster.html"><![CDATA[Roster]]></category>
		<category domain="http://resources.bnet.com/topic/united.html"><![CDATA[United]]></category>
		<category domain="http://resources.bnet.com/topic/vertex+pharmaceuticals+inc..html"><![CDATA[Vertex Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ACOR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CLAY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DEL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XRAY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DHOM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DCO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ECL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FDS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">FPL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GAN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HHS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HIG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HWAY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">KCI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LAB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MTSN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VRTX</category>
		<category domain="tickers">ACOR,ALB,ALNY,CE,CLAY,DEL,XRAY,DHOM,DCO,ECL,FDS,FPL,GAN,HHS,HIG,HWAY,KCI,LAB,MTSN,VRTX</category>
	</item>
</channel>
</rss>
